About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next yearโ€™s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

Visit the new ELF Sarcoidosis Patient Priorities website

Visit the ELF Sarcoidosis Patient Priorities Website graphics

ELF has recently launched a new website providingย information about sarcoidosisย for people with the condition and their family members and caregivers during Sarcoidosis Awareness Month, with the aim to raise awareness of this rare condition and signpost to useful resources and organisations in Europe and beyond.

The website includes a new resource, theย Sarcoidosis Patient Compass. This is an interactive tool to help people navigate their own sarcoidosis journey, and to highlight key questions they may want to ask healthcare professionals involved in their care. The patient compass is available to download for free and is available in Dutch, English, French, German and Italian with versions in Serbian and Spanish coming soon.

The website also links toย patient support organisationsย across the globe who you can contact to get more detailed information about sarcoidosis in your own language.

The website has been developed with input from the ELF sarcoidosis patient advisory group and healthcare experts from the European Respiratory Society in the sarcoidosis field from around the world.